HBOT for Long COVID Real or Hype

Is hyperbaric oxygen therapy the miracle cure for long COVID—or just another expensive gamble? Some patients are reporting dramatic recoveries after breathing pure oxygen in pressurized chambers, with claims of restored cognition and energy. But the science is murky: while some studies show lasting benefits, others find no effect, and experts warn that protocol matters. Safety concerns loom too—especially for those with post-exertional malaise—and unregulated clinics add risk. Not FDA-approved, not covered by insurance, and wildly expensive, HBOT remains out of reach for most, leaving hopeful patients to weigh hype against real-world caution. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/5873cf3850bd6e3b